UNSPSC 85524059: Replacement of right axillary vein with synthetic substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to replacement of right axillary vein with synthetic substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 05R74JZ

UNSPSC 85524059 (Replacement of right axillary vein with synthetic substitute, percutaneous endoscopic approach), a Commodity code, shows no relevant recent state and local procurement activity. The code describes a specific surgical procedure, but the six posted opportunities under this code listing span occupational medical surveillance, pharmacy benefit management, temporary health professional staffing, independent medical evaluations for pension disability determinations, surgical benefit carve-out programs, and emergency medical services for detained youth—none of which involve vascular replacement procedures or the clinical intervention the code nominally describes. The mismatch between the code's procedural specificity and the actual scope of work being solicited suggests either miscategorization in the issuing bodies' tagging systems or a systematic data-entry error in how these opportunities were indexed to this UNSPSC code.

State and local procurement bodies posting under this code include county health systems (Santa Clara), county human resources and pension boards (Phoenix, Collier County), state transportation agencies (Washington State Department of Transportation), county detention authorities (Harris County Juvenile Probation), and municipal benefits offices (City of Long Beach). Geographic activity spans Arizona, California, Florida, Washington, and Texas. Without opportunities that actually target vascular surgical supplies or services aligned to the code's clinical scope, this code does not represent a viable pursuit avenue for firms offering replacement grafts, endoscopic instrumentation, or related surgical products or services to state and local government.